M&A · Financials · Finance Services
Renovaro, Inc. to acquire Predictive Oncology Inc.
Announced Jan 6, 2025 · Announced
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Renovaro, Inc. (RENB)
- Target
- Predictive Oncology Inc. (POAI)
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Announced
Deal protections
Not yet read from the merger agreement.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Sector context · Financials
- Comparable deals
- 59 in the prior 24 months
- Premium
- Sector median 34.0%
- EV / Adj. EBITDA
- Sector median 13.7x
- Break fee
- Sector median 3.3%
Timeline
- AnnouncedJan 6, 2025
- ClosedPending